Asthma & COPD Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Asthma & COPD Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Asthma & COPD Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Anti-inflammatory Drugs
- 1.3.3 Bronchodilator Monotherapy
- 1.3.4 Combination Drugs
1.4 Market Segment by Application
- 1.4.1 Global Asthma & COPD Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Private Clinics
- 1.4.4 Drug Stores
- 1.4.5 Retail Pharmacies
- 1.4.6 E-Commerce
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Asthma & COPD Market Size
- 2.1.1 Global Asthma & COPD Revenue 2014-2025
- 2.1.2 Global Asthma & COPD Sales 2014-2025
2.2 Asthma & COPD Growth Rate by Regions
- 2.2.1 Global Asthma & COPD Sales by Regions 2014-2019
- 2.2.2 Global Asthma & COPD Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Asthma & COPD Sales by Manufacturers
- 3.1.1 Asthma & COPD Sales by Manufacturers 2014-2019
- 3.1.2 Asthma & COPD Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Asthma & COPD Revenue by Manufacturers (2014-2019)
- 3.2.2 Asthma & COPD Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Asthma & COPD Market Concentration Ratio (CR5 and HHI)
3.3 Asthma & COPD Price by Manufacturers
3.4 Key Manufacturers Asthma & COPD Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Asthma & COPD Market
3.6 Key Manufacturers Asthma & COPD Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Anti-inflammatory Drugs Sales and Revenue (2014-2019)
- 4.1.2 Bronchodilator Monotherapy Sales and Revenue (2014-2019)
- 4.1.3 Combination Drugs Sales and Revenue (2014-2019)
4.2 Global Asthma & COPD Sales Market Share by Type
4.3 Global Asthma & COPD Revenue Market Share by Type
4.4 Asthma & COPD Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Asthma & COPD Sales by Application

6 United States

6.1 United States Asthma & COPD Breakdown Data by Company
6.2 United States Asthma & COPD Breakdown Data by Type
6.3 United States Asthma & COPD Breakdown Data by Application

7 European Union

7.1 European Union Asthma & COPD Breakdown Data by Company
7.2 European Union Asthma & COPD Breakdown Data by Type
7.3 European Union Asthma & COPD Breakdown Data by Application

8 China

8.1 China Asthma & COPD Breakdown Data by Company
8.2 China Asthma & COPD Breakdown Data by Type
8.3 China Asthma & COPD Breakdown Data by Application

9 Rest of World

9.1 Rest of World Asthma & COPD Breakdown Data by Company
9.2 Rest of World Asthma & COPD Breakdown Data by Type
9.3 Rest of World Asthma & COPD Breakdown Data by Application
9.4 Rest of World Asthma & COPD Breakdown Data by Countries
- 9.4.1 Rest of World Asthma & COPD Sales by Countries
- 9.4.2 Rest of World Asthma & COPD Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Asthma & COPD Sales Channels
- 11.2.2 Asthma & COPD Distributors
11.3 Asthma & COPD Customers

12 Market Forecast

12.1 Global Asthma & COPD Sales and Revenue Forecast 2019-2025
12.2 Global Asthma & COPD Sales Forecast by Type
12.3 Global Asthma & COPD Sales Forecast by Application
12.4 Asthma & COPD Forecast by Regions
- 12.4.1 Global Asthma & COPD Sales Forecast by Regions 2019-2025
- 12.4.2 Global Asthma & COPD Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
In 2019, the market size of Asthma & COPD is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Asthma & COPD.

This report studies the global market size of Asthma & COPD, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Asthma & COPD sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn

Market Segment by Product Type
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs

Market Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Asthma & COPD status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Asthma & COPD manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Asthma & COPD are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025